Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 19 Clinical Trials by Phase in E7 Countries 20 Clinical Trials in E7 Countries by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Clinical Trials by End Point Status 25 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28 Top Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials 30 Prominent Drugs 32 Clinical Trial Profile Snapshots 33 Appendix 153 Abbreviations 153 Definitions 153 Research Methodology 154 Secondary Research 154 About GlobalData 155 Contact Us 155 Disclaimer 155 Source 156

List of Tables Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, G7 Countries (%), 2016* 16 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, E7 Countries (%), 2016* 19 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Phase, 2016* 22 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32 List of Figures Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, E7 Countries (%), 2016* 19 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30 Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32 GlobalData Methodology 154

F. Hoffmann-La Roche Ltd. Novartis AG Nestle S.A. Meda AB The LEO Foundation Bristol-Myers Squibb Company Ignyta, Inc. Eli Lilly and Company Curis, Inc. Biosceptre (Aust) Pty Ltd